TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The Nobel Assembly awarded the 2026 Nobel Prize in Physiology or Medicine to Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries that enabled optogenetics. The technique uses light-sensitive proteins to control selected nerve cells, helping researchers study brain circuits; it is primarily a research tool, not an established treatment.
The Nobel Assembly at Karolinska Institute awarded the 2026 Nobel Prize in Physiology or Medicine to Karl Deisseroth, Peter Hegemann and Georg Nagel for research that enabled optogenetics, a method using light-sensitive proteins to control nerve cells. The technique gives scientists a way to switch selected cells and circuits on or off and study how they contribute to brain activity and behavior.
The work brought together discoveries about light-gated ion channels and the development of a means to use them in nerve cells. Hegemann studied how single-celled green algae respond to light. He and Nagel identified a protein that opens a channel when exposed to blue light, producing an electrical impulse. Introducing the protein into other cells can make those cells responsive to light.
Deisseroth then worked with the gene controlling the protein to build a light-controlled switch for neurons in living mice. He developed tiny fibers to deliver light to cells modified with the light-sensitive gene. The Nobel Assembly said the method is now used in laboratories around the world to investigate the brain.
Optogenetics is mainly a research technique, rather than a routine treatment. Deisseroth said researchers use it to investigate how particular neurons and neural circuits function. He described other approaches to controlling neurons as areas of ongoing study and said a direct optogenetics technique is being used to test an intervention for a genetic form of vision loss, retinitis pigmentosa.
A Precise Way to Test Brain Circuits
Optogenetics lets researchers manipulate selected nerve cells while observing what follows, offering a way to test whether particular cells or circuits contribute to a biological process. That precision can help scientists map connections between neural activity and behavior and investigate what changes when a circuit is disrupted.
The implications reach beyond basic neuroscience, but the prize does not mean that optogenetics has produced established treatments for the conditions it may help researchers understand. Nobel Assembly member Abdel El Manira said the technique has helped reveal circuit disruptions with implications for conditions including blindness, depression, addiction and dementia. Those are research implications, not evidence that optogenetics treats those conditions.
University of Pittsburgh researcher Jeremy Berg, who was at the NIH when it funded Deisseroth’s early work, called the approach a precise set of tools for experiments that would be difficult to conduct in other ways. The method’s value is its ability to probe brain function experimentally; how that knowledge might translate into clinical care remains a separate question.
As an affiliate, we earn on qualifying purchases.
From Algae to Living Neurons
The research began with a question about how green algae swim toward light. Hegemann’s work on the organism and the subsequent collaboration with Nagel led to the identification of a protein that responds to blue light by opening an ion channel. That finding supplied a biological component researchers could use to control electrical activity in other cells.
Deisseroth’s contribution was to adapt the light-sensitive system for nerve cells and deliver light to them in the brain. Together, the discoveries created what the Nobel Assembly described as a new era in neuroscience: researchers could use light not simply to observe activity, but to cause targeted changes and examine their effects.
The Assembly said the method has helped scientists study pathways involved in behavior and disease. The award’s announcement in Stockholm opened Nobel week. The medicine prize carries 12 million Swedish kronor, about $1.2 million, whether awarded to one person, a group of laureates or an organization.
“People usually think about light as a way of collecting information to observe things. But this is the opposite of that. This is using light to control things, to make things happen, and to do it in a very precise way.”
— Karl Deisseroth, as quoted by MedPage Today
light-controlled neuron stimulation device
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Research Uses and Treatment Limits
The award recognizes foundational research and a tool for investigating neural circuits; it does not establish optogenetics as a treatment for the conditions named by the Nobel Assembly. The source report says a direct optogenetics approach is being used to test an intervention for retinitis pigmentosa, but does not provide trial details, results, participant numbers or a timeline for clinical assessment.
It is also not clear from the report which other techniques for switching neurons on or off are under study, or how widely those approaches may be used. The laureates’ individual contributions are described through the sequence of discoveries, but the source does not give further detail on how the prize is divided among them.
As an affiliate, we earn on qualifying purchases.
Nobel Week and Ongoing Research
The medicine award began Nobel week, with the physics prize scheduled for Tuesday, chemistry for Wednesday and literature for Thursday. The Peace Prize is due Friday, followed by the Nobel Memorial Prize in Economic Sciences on Oct. 12.
For optogenetics, the next developments will come through continuing laboratory and clinical research. The report identifies an ongoing test involving genetic vision loss, but provides no date for results. The Nobel Assembly’s broader point is that the technique offers researchers a way to investigate remaining questions about the brain; what those findings may eventually mean for patient care is still to be determined.
light-sensitive proteins for neuroscience
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Who won the Nobel Prize in Physiology or Medicine?
Karl Deisseroth, Peter Hegemann and Georg Nagel received the prize for research that enabled optogenetics.
What is optogenetics?
Optogenetics uses light-sensitive proteins to make selected cells responsive to light. Researchers can then use light to control nerve-cell activity and study how specific brain circuits work.
Is optogenetics an established treatment?
No. The source describes optogenetics primarily as a research technique. It reports that a direct approach is being tested for a genetic form of vision loss, but does not report trial outcomes or establish it as routine care.
How much is the Nobel medicine prize worth?
The prize money is 12 million Swedish kronor, about $1.2 million, according to the report.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
